Overall survival worse with multiple primary melanomas

Overall survival worse with multiple primary melanomas

(HealthDay)—Patients with multiple primary melanomas have worse overall survival than those with a single primary melanoma, according to a study published online June 26 in JAMA Dermatology.

Mary-Ann El Sharouni, M.D., from the University Medical Center Utrecht in the Netherlands, and colleagues described the epidemiologic features of multiple primary in a retrospective population-based cohort study. Adults with histologically proven, primary, during Jan. 1, 2000, through Dec. 31, 2014, were followed for a median of 75.1 months. Data were included for 56,929 patients total (54,645 single primary melanomas and 4,967 multiple primary melanomas in 2,284 patients).

The researchers found a decrease in the median Breslow thickness from 0.90 mm for the first melanoma to 0.65 mm for the second melanoma. For the second melanoma, 16.2 percent of patients had a higher T stage, 48.7 percent had the same T stage, and 35.1 percent had a lower T stage. In patients with multiple primary melanomas, 36.8 and 27.3 percent were found during the first year of follow-up and after five years of follow-up, respectively. Patients with multiple primary melanomas had worse overall survival than those with a single primary melanoma (hazard ratio, 1.31).

"The findings suggest that current melanoma follow-up strategies need to be reconsidered for patients with multiple primary melanomas and guidelines should comment on this," the authors write.

Explore further

Hypervigilance critical for difficult-to-detect melanoma

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: JAMA Dermatology

Copyright © 2019 HealthDay. All rights reserved.

Citation: Overall survival worse with multiple primary melanomas (2019, July 1) retrieved 18 January 2022 from https://medicalxpress.com/news/2019-07-survival-worse-multiple-primary-melanomas.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors